School of Medicine and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, Sichuan, China.
Key Laboratory of Reproductive Medicine, Sichuan Provincial Maternity and Child Health Care Hospital, The Affiliated Women's and Children's Hospital of Chengdu Medical College, Chengdu, 610045, China.
J Nanobiotechnology. 2024 Jun 11;22(1):330. doi: 10.1186/s12951-024-02602-5.
The cryopreservation and transplantation of ovarian tissue underscore its paramount importance in safeguarding reproductive capacity and ameliorating reproductive disorders. However, challenges persist in ovarian tissue cryopreservation and transplantation (OTC-T), including the risk of tissue damage and dysfunction. Consequently, there has been a compelling exploration into the realm of nanoregulators to refine and enhance these procedures. This review embarks on a meticulous examination of the intricate anatomical structure of the ovary and its microenvironment, thereby establishing a robust groundwork for the development of nanomodulators. It systematically categorizes nanoregulators and delves deeply into their functions and mechanisms, meticulously tailored for optimizing ovarian tissue cryopreservation and transplantation. Furthermore, the review imparts valuable insights into the practical applications and obstacles encountered in clinical settings associated with OTC-T. Moreover, the review advocates for the utilization of microbially derived nanomodulators as a potent therapeutic intervention in ovarian tissue cryopreservation. The progression of these approaches holds the promise of seamlessly integrating nanoregulators into OTC-T practices, thereby heralding a new era of expansive applications and auspicious prospects in this pivotal domain.
卵巢组织的冷冻保存和移植强调了其在保护生殖能力和改善生殖障碍方面的至关重要性。然而,卵巢组织冷冻保存和移植(OTC-T)仍然存在挑战,包括组织损伤和功能障碍的风险。因此,人们强烈探索纳米调节剂领域,以改进和增强这些程序。
本综述从卵巢及其微环境的复杂解剖结构开始,进行了细致的检查,从而为纳米调节剂的开发奠定了坚实的基础。它系统地对纳米调节剂进行了分类,并深入研究了它们的功能和作用机制,精心设计以优化卵巢组织的冷冻保存和移植。
此外,本综述还介绍了 OTC-T 临床应用中遇到的实际应用和障碍方面的宝贵见解。此外,本综述主张将微生物衍生的纳米调节剂用作卵巢组织冷冻保存的有效治疗干预措施。这些方法的进展有望将纳米调节剂无缝集成到 OTC-T 实践中,从而为这个关键领域带来广泛应用和光明前景的新时代。